Related Experiment Videos
Antibiotic prophylaxis for prostatic surgery. Single-dose cephradine compared with single-dose cefotaxime
British Journal of Urology
|April 1, 1987
Summary
Single doses of cefotaxime or cephradine are effective for antibiotic prophylaxis in prostatic surgery. A 5-year study found no emergence of resistant bacterial strains, confirming the continued efficacy of these antibiotic regimens.
Area of Science:
- Urology
- Infectious Diseases
- Pharmacology
Background:
- Antibiotic prophylaxis is crucial for reducing infection risk in prostatic surgery.
- Previous studies support the use of prophylactic antibiotics for these procedures.
Purpose of the Study:
- To compare the efficacy of single-dose cefotaxime versus cephradine for antibiotic prophylaxis in prostatic surgery.
- To assess the long-term impact of antibiotic prophylaxis on ward flora and bacterial resistance over a 5-year period.
Main Methods:
- A prospective randomized study comparing single-dose cefotaxime and cephradine at anesthesia induction.
- A 5-year survey of ward flora to monitor for changes in bacterial susceptibility.
Main Results:
- No significant difference was observed between cefotaxime and cephradine regimens.
- The 5-year survey revealed no significant changes in ward flora or emergence of resistant bacterial strains.
Conclusions:
- Either cefotaxime or cephradine can be used for antibiotic prophylaxis in prostatic surgery, based on availability and cost.
- Current antibiotic prophylaxis strategies have not led to the emergence of resistant strains in the studied ward flora.